Projected Income Statement: Procter & Gamble Company

Forecast Balance Sheet: Procter & Gamble Company

Forecast Balance Sheet - Procter & Gamble Company
Fiscal Period: June 2022 2023 2024 2025 2026 2027 2028 2029
Net Debt 1 24,279 26,361 22,978 24,952 24,196 26,081 25,376 24,054
Change - 8.58% -12.83% 8.59% -3.03% 7.79% -2.7% -5.21%
Announcement Date 7/29/22 7/28/23 7/30/24 7/29/25 7/29/26 - - -
1USD in Million
Estimates

Cash Flow Forecast: Procter & Gamble Company

Fiscal Period: June 2022 2023 2024 2025 2026 2027 2028 2029
CAPEX 1 3,156 3,062 3,322 3,773 4,409 4,550 4,266 4,306
Change - -2.98% 8.49% 13.58% 16.86% 3.2% -6.25% 0.95%
Free Cash Flow (FCF) 1 13,567 13,786 16,524 14,606 15,147 15,584 16,359 17,719
Change - 1.61% 19.86% -11.61% 3.7% 2.89% 4.97% 8.32%
Announcement Date 7/29/22 7/28/23 7/30/24 7/29/25 7/29/26 - - -
1USD in Million
Estimates

Forecast Financial Ratios: Procter & Gamble Company

Fiscal Period: June 2022 2023 2024 2025 2026 2027 2028 2029

Profitability

        
EBITDA Margin (%) 25.71% 25.42% 27.23% 27.65% 27.18% 27.32% 27.78% 28.1%
EBIT Margin (%) 22.21% 22.11% 23.78% 24.27% 23.55% 23.59% 24.02% 24.27%
EBT Margin (%) 22.44% 22.38% 22.32% 23.93% 23.41% 23.08% 23.81% 24.06%
Net margin (%) 18.38% 17.87% 17.7% 18.95% 18.44% 18.33% 18.97% 19.17%
FCF margin (%) 16.92% 16.81% 19.66% 17.33% 17.4% 17.35% 17.64% 18.44%
FCF / Net Income (%) 92.03% 94.08% 111.06% 91.44% 94.4% 94.68% 93.01% 96.22%

Profitability

        
ROA 12.47% 12.31% 13.39% 12.9% 12.75% 12.73% 13.15% 13.47%
ROE 31.53% 31.2% 30.48% 31.06% 30.11% 30.55% 31.75% 32.61%

Financial Health

        
Leverage (Debt/EBITDA) 1.18x 1.26x 1x 1.07x 1.02x 1.06x 0.99x 0.89x
Debt / Free cash flow 1.79x 1.91x 1.39x 1.71x 1.6x 1.67x 1.55x 1.36x

Capital Intensity

        
CAPEX / Current Assets (%) 3.94% 3.73% 3.95% 4.48% 5.07% 5.07% 4.6% 4.48%
CAPEX / EBITDA (%) 15.31% 14.69% 14.52% 16.19% 18.64% 18.54% 16.56% 15.95%
CAPEX / FCF (%) 23.26% 22.21% 20.1% 25.83% 29.11% 29.2% 26.08% 24.3%

Items per share

        
Cash flow per share 1 6.586 6.783 8.029 7.259 8.073 8.355 9.208 9.682
Change - 2.99% 18.37% -9.58% 11.21% 3.49% 10.22% 5.15%
Dividend per Share 1 3.523 3.681 3.829 4.076 4.259 4.403 4.603 4.823
Change - 4.47% 4.02% 6.47% 4.48% 3.37% 4.56% 4.77%
Book Value Per Share 1 19.57 19.8 20.45 21.3 22.42 23.67 24.5 25.58
Change - 1.18% 3.28% 4.15% 5.24% 5.59% 3.48% 4.43%
EPS 1 5.81 5.9 6.02 6.51 6.62 6.873 7.385 7.802
Change - 1.55% 2.03% 8.14% 1.69% 3.83% 7.44% 5.65%
Nbr of stocks (in thousands) 2,399,297 2,356,969 2,360,135 2,344,542 2,328,599 2,317,783 2,317,783 2,317,783
Announcement Date 7/29/22 7/28/23 7/30/24 7/29/25 7/29/26 - - -
1USD
Estimates
2027 *2028 *
P/E 24.6x 22.9x
PBR 7.15x 6.91x
EV / Sales 4.66x 4.51x
Yield 2.6% 2.72%

EPS & Dividend

EPS & Dividend - Procter & Gamble Company


Y-o-Y evolution of P/E

Valuation ratios - P/E - Procter & Gamble Company
 

Year-on-year evolution of the Yield

Valuation ratios - Yield - Procter & Gamble Company
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Procter & Gamble Company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
169.37USD
Average target price
175.83USD
Spread / Average Target
+3.81%
  1. Stock Market
  2. Stocks
  3. PG Stock
  4. Financials Procter & Gamble Company